The historical diagnosis of Prader-Willi syndrome (PWS), a complex genetic disorder, in adults is often achieved by clinical presentation rather than by genetic testing and thus limited genetic subtype-specific psychometric investigations and treatment options. Genetic testing and clinical psychiatric evaluation using Diagnostic and Statistical Manual (DSM)-IV-TR criteria were undertaken on 72 adult residents (34 M; 38 F) from the Prader-Willi Homes of Oconomowoc (PWHO), a specialty PWS group home system. Methylation specific-multiplex ligation probe amplification and high-resolution microarrays were analyzed for methylation status, 15q11-q13 deletions and maternal uniparental disomy 15 (mUPD15). Seventy (33M; 37F) of 72 residents were genetically confirmed and 36 (51%) had Type I or Type II deletions; 29 (42%) with mUPD15 and 5 (7%) with imprinting defects from three separate families. Psychiatric comorbidities were classified as anxiety disorder (38%), excoriation (skin picking) (33%), intermittent explosive disorder ([30%-predominantly among males at 45% compared with females at 16%
The causation of PWS is due to loss of expression of paternally derived genes in the 15q11-q13 region generally from a de novo deletion followed by maternal uniparental disomy 15 (both copies of chromosome 15 from the mother). A small percentage of patients with PWS have an imprinting defect which may be inherited and account for a potential 50% recurrence risk for subsequent affected children. 4, 5, 7 The PWS genetic subtypes include the paternal 15q11-q13 deletion seen in about 70% of cases and has three subtypes (larger Type I, smaller Type II and an atypical size). These deletions generally involve three common breakpoints (BPs) within the 15q11-q13 region (ie proximal BP1 and BP2 and distal BP3). 9, 10 Maternal uniparental disomy 15 is seen in about 30% of cases and is now recognized to occur in different subclasses such as maternal heterodisomy, segmented isodisomy or total isodisomy of chromosome 15 depending on crossing-over events and nondisjunction in meiosis I or meiosis II. 5 Imprinting defects represent only a few percentage of cases and are due to either a small microdeletion of the imprinting center which controls the activity of imprinting genes in the 15q11-q13 region or from errors in methylation processing or epimutations. 4, 5, 7, [11] [12] [13] [14] Studies in individuals with the typical Type I deletion which involves BP1 and BP3 includes TUBGCP5, CYFIP1, NIPA1 and NIPA2
genes located between BP1 and BP2, in both Prader-Willi and Angelman syndromes have been reported with more severe neurodevelopmental disturbances compared to those individuals with the smaller Type II deletion involving BP2 and BP3 and the four genes intact. 15 Several studies have been undertaken in the pediatric age group with limited information in adults particularly in those living in residential care. Individuals with deletions of the 15q11.2 BP1-BP2 cytogenetic region alone can present with developmental and language delay, neurobehavioral disturbances, psychiatric problems, autism, seizures, schizophrenia and mild dysmorphic features. However, not all individuals who carry the BP1-BP2 microdeletion are clinically affected, as the phenotype can show incomplete penetrance and variable expressivity. 16, 17 The type and accuracy of genetic testing for PWS has progressed over the years beginning in the 1980s with high-resolution chromosome testing to identify the 15q11-q13 deletion. 18 Later, polymorphic DNA markers from chromosome 15 were used to identify the parental origin and maternal uniparental disomy 15 status. 19 Fluorescence in situ hybridization (FISH) with DNA probes from the 15q11-q13 region were introduced in the early 1990s but could not distin- 
| Description of adults with Prader-Willi syndrome
There were 84 adult residents with PWS residing at PWHO at the time of this study representing all regions of the United States.
Their mean age was 37 AE 10 years and ranged from 18 to 61 years. Only 10 adults were genetically confirmed previously while 74 were diagnosed clinically based on established PWS consensus diagnostic criteria at the time of admission to PWHO. 28 Seventy-three of the 84 subjects agreed to consent and participate in the study which was approved by the local human subjects research committee.
| Genetic testing methods and analysis
Each subject or legal guardian signed the approved consent forms, a saliva sample (2 mL aliquots) was collected and DNA isolated using (see Figure 1 ). High-resolution Affymetrix 6.0 version (Santa Clara, California) microarrays were performed using 1.8 million copy number variant (CNV) and SNP probes to identify chromosome 15q11-q13 deletions and maternal uniparental disomy 15 status.
Genotyping of DNA microsatellite markers from chromosome 15 were also undertaken by PCR using subject and parental DNA samples to identify imprinting defects specifically in adults with an abnormal PWS methylation pattern but no recognized deletion.
Chromosomal microarrays with SNP probes were used to detect maternal uniparental 15 status (heterodisomy, segmental isodisomy, total isodisomy) (see Figure 2A ,B).
Copy number variants (deletions or duplications) using the high-resolution microarrays were defined as a size ≥100 kb with at 3 | RESULTS
| Clinical, psychiatric and genetic findings
Seventy-three adult residents from PWHO participated in the study.
Seventy-two subjects completed the PWS genetic subtyping process using the MS-MLPA assay initially then followed by high-resolution chromosomal microarray analysis needed if a chromosome 15q11-q13 deletion was not found. The clinical diagnosis of PWS was not confirmed by chromosomal and DNA methylation testing in two PWHO females who exhibited cardinal clinical features of PWS including hypotonia, short stature with small hands and feet along with a history of behavioral issues including impulsive aggression, obesity and food-seeking. One subject showed significant skin- a Seventy-three subjects were screened and 70 showed genetic confirmation of PWS. One subject was excluded due to an inadequate DNA sample and two subjects were excluded due to normal DNA methylation results.
b Three siblings (2 males and 1 female) from a single family with PWS and imprinting disorder at the PWHO group home had the same microdeletion of the imprinting center (imprinting defect) identified with MS-MLPA and by high-resolution SNP microarray analysis. a Odds ratio for males relative to females using Logit.
b P < 0.05 considered significant.
picking. These two females were dropped from our analyses. Table 1a shows the summary of age at the time of the neuropsychiatric assessment for this study, gender, age at PWHO admission, BMI (kg/m 2 ) and number of psychiatric diagnoses for the 70 genetically confirmed PWHO residents. There was no evidence of consanguinity among the PWHO subjects using high-resolution SNP microarray data to identify the SNP pattern and calculate the percentage of regions of homozygosity (ROH) for all chromosomes following protocols reported previously. 31, 32 Twenty-three representative obesity genes (FTO, BDNF, SIM1) 5, 29 known to contribute to obesity-related genetic disorders were examined more closely for possible microdeletions by relaxing the classification cut-off parameters of the microarray data (from 100 kb to 25 kb and 50 to 35 markers) utilizing the standard computer software program. No deletions were found encompassing the 23 genes studied using the less stringent copy number variant classification criteria.
Of the 36 subjects with a 15q11-q13 deletion, 14 had Type I and 22 had Type II deletions (see Figure 2A ). No differences were seen between the two deletion subtypes in mean age, BMI or age at admission to PWHO. The average number of psychiatric diagnoses per subject was 4.3 AE 1.2 with a range of 2 to 7 for those with Type I deletion and 3.6 AE 1.0 with a range of 2 to 5 for the Type II deletion group. Of the 29 subjects with maternal disomy 15, 10 showed heterodisomy, 15 showed segmental isodisomy and 4 showed isodisomy for the entire chromosome 15 (see Figure 2B ). a Odds ratio for UPD15 relative to deletion subtype using Logit.
b P < 0.05 considered significant. mean age, BMI, age at admission to PWHO or number of psychiatric diagnoses.
| Neuropsychiatric diagnostic outcomes
The frequency of primary neuropsychiatric diagnoses according to DSM-IV-TR criteria and classification is summarized in Table 2 were diagnosed with Intermittent Explosive Disorder (IED) with twice the number of males than females in this category (see Table 2 ; OR = 4.3, 95% CI 1.4,13.1, P < 0.008). Twenty-three (33%-15 F; 8 M)
were diagnosed with Impulse-Control Disorder Not Otherwise Specified and in all cases due to recurrent skin picking. There were additional low frequency diagnoses identified including but not limited to Attention Deficit Disorder, Conduct Disorder, Tic Disorders and Learning Disorders which were excluded from analysis.
A significant positive correlation was found between age and BMI (r = 0.27, P < 0.027), while a significant negative correlation was found between age and number of psychiatric disorders (r = −0.24; P < 0.042). The number of psychiatric disorders was not related to BMI or age at PWHO admission for our PWS study participants.
Examination of the relationship between the psychiatric diagnoses and PWS genetic subtype showed no statistically significant differences in the frequency of primary psychiatric diagnoses between those with the 15q11-q13 deletion subtypes and maternal disomy 15 subclasses (see Table 3 ). Similarly, there were no statistically significant differences in the frequency of primary psychiatric diagnoses between those with Type I vs Type II deletion subtypes or among the three mUPD15 subtypes. The average number of psychiatric diagnoses were significantly higher for those with the Type I deletion subtype when age differences were controlled (see Figure 4A) . Similarly, BMI was significantly higher for those with the Type II deletion subtype when age differences were controlled (see Figure 4B ).
| DISCUSSION
The frequency and pattern of our neuropsychiatric diagnoses based on DSM-IV-TR criteria and classification were described in adults with PWS in residential care. The population of individuals with PWS in our PWHO cohort is fundamentally different than previous PWS populations studied. Our residential adults showed less neuropsychiatric stability than nonresidential populations at initial assessments. 
